Martens K - Search Results

1

PREPL: a putative novel oligopeptidase propelled into the limelight.

Martens K, Derua R, Meulemans S, Waelkens E, Jaeken J, Matthijs G, Creemers JW. Martens K, et al. Biol Chem. 2006 Jul;387(7):879-83. doi: 10.1515/BC.2006.111. Biol Chem. 2006. PMID: 16913837 Review.

2

Deletion of PREPL, a gene encoding a putative serine oligopeptidase, in patients with hypotonia-cystinuria syndrome.

Jaeken J, Martens K, Francois I, Eyskens F, Lecointre C, Derua R, Meulemans S, Slootstra JW, Waelkens E, de Zegher F, Creemers JW, Matthijs G. Jaeken J, et al. Among authors: martens k. Am J Hum Genet. 2006 Jan;78(1):38-51. doi: 10.1086/498852. Epub 2005 Nov 23. Am J Hum Genet. 2006. PMID: 16385448 Free PMC article.

3

Global distribution of the most prevalent deletions causing hypotonia-cystinuria syndrome.

Martens K, Heulens I, Meulemans S, Zaffanello M, Tilstra D, Hes FJ, Rooman R, François I, de Zegher F, Jaeken J, Matthijs G, Creemers JW. Martens K, et al. Eur J Hum Genet. 2007 Oct;15(10):1029-33. doi: 10.1038/sj.ejhg.5201881. Epub 2007 Jun 20. Eur J Hum Genet. 2007. PMID: 17579669

4

Multi-system disorder syndromes associated with cystinuria type I.

Martens K, Jaeken J, Matthijs G, Creemers JW. Martens K, et al. Curr Mol Med. 2008 Sep;8(6):544-50. doi: 10.2174/156652408785747997. Curr Mol Med. 2008. PMID: 18781961 Review.

5

Deletion of C2orf34, PREPL and SLC3A1 causes atypical hypotonia-cystinuria syndrome.

Chabrol B, Martens K, Meulemans S, Cano A, Jaeken J, Matthijs G, Creemers JW. Chabrol B, et al. Among authors: martens k. J Med Genet. 2008 May;45(5):314-8. doi: 10.1136/jmg.2007.055475. Epub 2008 Jan 30. J Med Genet. 2008. PMID: 18234729

6

Deletion of C2orf34, PREPL and SLC3A1 causes atypical hypotonia-cystinuria syndrome.

Chabrol B, Martens K, Meulemans S, Cano A, Jaeken J, Matthijs G, Creemers JW. Chabrol B, et al. Among authors: martens k. BMJ Case Rep. 2009;2009:bcr08.2008.0719. doi: 10.1136/bcr.08.2008.0719. Epub 2009 Feb 2. BMJ Case Rep. 2009. PMID: 21686663 Free PMC article.

7

DHPLC analysis as a platform for molecular diagnosis of congenital disorders of glycosylation (CDG).

Schollen E, Martens K, Geuzens E, Matthijs G. Schollen E, et al. Among authors: martens k. Eur J Hum Genet. 2002 Oct;10(10):643-8. doi: 10.1038/sj.ejhg.5200858. Eur J Hum Genet. 2002. PMID: 12357336

8

Autosomal-dominant microtia linked to five tandem copies of a copy-number-variable region at chromosome 4p16.

Balikova I, Martens K, Melotte C, Amyere M, Van Vooren S, Moreau Y, Vetrie D, Fiegler H, Carter NP, Liehr T, Vikkula M, Matthijs G, Fryns JP, Casteels I, Devriendt K, Vermeesch JR. Balikova I, et al. Among authors: martens k. Am J Hum Genet. 2008 Jan;82(1):181-7. doi: 10.1016/j.ajhg.2007.08.001. Am J Hum Genet. 2008. PMID: 18179897 Free PMC article.

9

The caregene study: muscle-specific creatine kinase gene and aerobic power in coronary artery disease.

Defoor J, Martens K, Matthijs G, Zieliñska D, Schepers D, Philips T, Vlietinck R, Fagard R, Vanhees L. Defoor J, et al. Among authors: martens k. Eur J Cardiovasc Prev Rehabil. 2005 Aug;12(4):415-7. doi: 10.1097/01.hjr.0000170266.30562.59. Eur J Cardiovasc Prev Rehabil. 2005. PMID: 16079652

10

The CAREGENE study: polymorphisms of the beta1-adrenoceptor gene and aerobic power in coronary artery disease.

Defoor J, Martens K, Zielinska D, Matthijs G, Van Nerum H, Schepers D, Fagard R, Vanhees L. Defoor J, et al. Among authors: martens k. Eur Heart J. 2006 Apr;27(7):808-16. doi: 10.1093/eurheartj/ehi737. Epub 2006 Jan 18. Eur Heart J. 2006. PMID: 16421173

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

348 results

Search Page

Filters